| Andreu AL et al. |
Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. |
1998 |
Neurology |
pmid:9818877
|
| Rahman S and Hargreaves IP |
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. |
2007 |
Neurology |
pmid:17515557
|
| Horvath R et al. |
Coenzyme Q10 deficiency and isolated myopathy. |
2006 |
Neurology |
pmid:16434667
|
| D'Andrea G et al. |
Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. |
2009 |
Neurol. Sci. |
pmid:19415441
|
| Rapoport AM and Bigal ME |
Preventive migraine therapy: what is new. |
2004 |
Neurol. Sci. |
pmid:15549532
|
| Rapoport AM and Bigal ME |
Migraine preventive therapy: current and emerging treatment options. |
2005 |
Neurol. Sci. |
pmid:15926007
|
| Carotenuto M and Esposito M |
Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I. |
2013 |
Neurol. Sci. |
pmid:23532548
|
| Naccarati A et al. |
Cytogenetic damage in peripheral lymphocytes of mitochondrial disease patients. |
2000 |
Neurol. Sci. |
pmid:11382196
|
| Tedeschi D et al. |
Potential involvement of ubiquinone in myotonic dystrophy pathophysiology: new diagnostic approaches for new rationale therapeutics. |
2000 |
Neurol. Sci. |
pmid:11382200
|
| Esposito M and Carotenuto M |
Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. |
2011 |
Neurol. Sci. |
pmid:20872034
|
| Castellotti B et al. |
Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. |
2011 |
Neurogenetics |
pmid:21465257
|
| Gironi M et al. |
Oxidative imbalance in different neurodegenerative diseases with memory impairment. |
2011 |
Neurodegener Dis |
pmid:20838029
|
| Li HN et al. |
Water-Soluble Coenzyme Q10 Reduces Rotenone-Induced Mitochondrial Fission. |
2017 |
Neurochem. Res. |
pmid:28190227
|
| Hasan SM et al. |
Oxidative stress alters physiological and morphological neuronal properties. |
2007 |
Neurochem. Res. |
pmid:17390220
|
| del Hoyo P et al. |
Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease. |
2006 |
Neurochem. Res. |
pmid:16944322
|
| Quinzii CM et al. |
Human coenzyme Q10 deficiency. |
2007 Apr-May |
Neurochem. Res. |
pmid:17094036
|
| Muralikrishnan D et al. |
Effect of MPTP on Dopamine metabolism in Ames dwarf mice. |
2002 |
Neurochem. Res. |
pmid:12199149
|
| Klongpanichapak S et al. |
Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10. |
2006 |
Neurochem. Res. |
pmid:16733807
|
| Land JM et al. |
Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency. |
2007 Apr-May |
Neurochem. Res. |
pmid:17186372
|
| Kasparová S et al. |
Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease. |
2006 |
Neurochem. Int. |
pmid:16290265
|
| Somayajulu M et al. |
Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10. |
2005 |
Neurobiol. Dis. |
pmid:15755687
|
| Ono K and Yamada M |
Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases. |
2007 |
Neurobiol. Dis. |
pmid:17169566
|
| Zhang YP et al. |
Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10. |
2013 |
Neurobiol. Dis. |
pmid:23684663
|
| Li G et al. |
Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein. |
2007 |
Neurobiol. Aging |
pmid:16806588
|
| Tiano L et al. |
Prolonged coenzyme Q10 treatment in Down syndrome patients: effect on DNA oxidation. |
2012 |
Neurobiol. Aging |
pmid:21601315
|
| Sikorska M et al. |
Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease. |
2014 |
Neurobiol. Aging |
pmid:24775711
|
| Phillipson OT |
Management of the aging risk factor for Parkinson's disease. |
2014 |
Neurobiol. Aging |
pmid:24246717
|
| Tiano L et al. |
Effect of Coenzyme Q10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial. |
2011 |
Neurobiol. Aging |
pmid:20022408
|
| Cordero MD et al. |
Oxidative stress and mitochondrial dysfunction in fibromyalgia. |
2010 |
Neuro Endocrinol. Lett. |
pmid:20424583
|
| Zlatohlavek L et al. |
The effect of coenzyme Q10 in statin myopathy. |
2012 |
Neuro Endocrinol. Lett. |
pmid:23183519
|
| Maes M et al. |
Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. |
2009 |
Neuro Endocrinol. Lett. |
pmid:20010493
|
| Maes M et al. |
Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. |
2009 |
Neuro Endocrinol. Lett. |
pmid:20010505
|
| Scheffer PG et al. |
No effect of atorvastatin and simvastatin on oxidative stress in patients at high risk for cardiovascular disease. |
2013 |
Neth J Med |
pmid:24038561
|
| Sparing R et al. |
[Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors]. |
2003 |
Nervenarzt |
pmid:12596018
|
| Triolo L et al. |
Serum coenzyme Q10 in uremic patients on chronic hemodialysis. |
1994 |
Nephron |
pmid:8139734
|
| GazdÃková K et al. |
Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients with a mild to moderate decrease of kidney function. |
2001 |
Nephron |
pmid:11423766
|
| Ito H et al. |
Coenzyme Q10 attenuates cyanide-activation of the ATP-sensitive K+ channel current in single cardiac myocytes of the guinea-pig. |
1991 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:1775189
|
| Payton S |
Stones: Coenzyme Q10 protects kidney during ESWL. |
2013 |
Nat Rev Urol |
pmid:24166344
|
| Emma F et al. |
Mitochondrial dysfunction in inherited renal disease and acute kidney injury. |
2016 |
Nat Rev Nephrol |
pmid:26804019
|
| Mugoni V et al. |
13C-isotope-based protocol for prenyl lipid metabolic analysis in zebrafish embryos. |
2013 |
Nat Protoc |
pmid:24177291
|
| López LC et al. |
Argan oil-contained antioxidants for human mitochondria. |
2013 |
Nat Prod Commun |
pmid:23472457
|
| Henchcliffe C and Beal MF |
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. |
2008 |
Nat Clin Pract Neurol |
pmid:18978800
|
| Ankola DD et al. |
Preparation, characterization and in silico modeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10. |
2010 |
Nanotechnology |
pmid:20061595
|
| Swarnakar NK et al. |
Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin. |
2014 |
Nanomedicine |
pmid:24637217
|
| Molyneux S et al. |
The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly. |
2004 |
N. Z. Med. J. |
pmid:15477929
|
| Montini G et al. |
Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. |
2008 |
N. Engl. J. Med. |
pmid:18579827
|
|
Mutations in COQ2 in familial and sporadic multiple-system atrophy. |
2013 |
N. Engl. J. Med. |
pmid:23758206
|
| Colucci WS et al. |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. |
1986 |
N. Engl. J. Med. |
pmid:2418353
|
| Florkowski CM et al. |
Rosuvastatin in older patients with systolic heart failure. |
2008 |
N. Engl. J. Med. |
pmid:18354111
|
| Schmelzer C and Döring F |
Micronutrient special issue: coenzyme Q(10) requirements for DNA damage prevention. |
2012 |
Mutat. Res. |
pmid:21964355
|
| Migliore L et al. |
Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy. |
2004 |
Mutagenesis |
pmid:14681312
|
| Wu CM et al. |
An experimental model of mitochondrial myopathy: germanium-induced myopathy and coenzyme Q10 administration. |
1992 |
Muscle Nerve |
pmid:1488063
|
| Glover EI et al. |
A randomized trial of coenzyme Q10 in mitochondrial disorders. |
2010 |
Muscle Nerve |
pmid:20886510
|
| Baker SK |
Molecular clues into the pathogenesis of statin-mediated muscle toxicity. |
2005 |
Muscle Nerve |
pmid:15712281
|
| Rodriguez MC et al. |
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. |
2007 |
Muscle Nerve |
pmid:17080429
|
| Sommerville RB et al. |
Coenzyme Q10 deficiency in children: frequent type 2C muscle fibers with normal morphology. |
2013 |
Muscle Nerve |
pmid:23494902
|
| Spurney CF et al. |
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. |
2011 |
Muscle Nerve |
pmid:21698649
|
| Stamelou M et al. |
Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. |
2008 |
Mov. Disord. |
pmid:18464278
|
| Thomas B and Beal MF |
Mitochondrial therapies for Parkinson's disease. |
2010 |
Mov. Disord. |
pmid:20187246
|
| Lo RY et al. |
Coenzyme Q10 and spinocerebellar ataxias. |
2015 |
Mov. Disord. |
pmid:25449974
|
| Chandra A et al. |
Prospects for neuroprotective therapies in prodromal Huntington's disease. |
2014 |
Mov. Disord. |
pmid:24573776
|
| Chariot P et al. |
Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy. |
1999 |
Mov. Disord. |
pmid:10495052
|
| Feigin A et al. |
Assessment of coenzyme Q10 tolerability in Huntington's disease. |
1996 |
Mov. Disord. |
pmid:8723151
|
| de Lau LM et al. |
Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease. |
2007 |
Mov. Disord. |
pmid:17557354
|
| Schapira AH |
Future directions in the treatment of Parkinson's disease. |
2007 |
Mov. Disord. |
pmid:18175401
|
| Hyson HC et al. |
Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects. |
2010 |
Mov. Disord. |
pmid:20669312
|
| Olanow CW and Jankovic J |
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. |
2005 |
Mov. Disord. |
pmid:15822111
|
| Pineda M et al. |
Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up. |
2010 |
Mov. Disord. |
pmid:20629161
|
| Huang ZR et al. |
Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. |
2009 |
Molecules |
pmid:19169201
|
| Chen Y et al. |
Efficient Lewis acid ionic liquid-catalyzed synthesis of the key intermediate of coenzyme Q10 under microwave irradiation. |
2010 |
Molecules |
pmid:21178903
|
| Tommasini I et al. |
Delayed formation of hydrogen peroxide mediates the lethal response evoked by peroxynitrite in U937 cells. |
2002 |
Mol. Pharmacol. |
pmid:11901226
|
| Morris G et al. |
Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications. |
2013 |
Mol. Neurobiol. |
pmid:23761046
|
| Ferdinandusse S et al. |
Evidence for increased oxidative stress in peroxisomal D-bifunctional protein deficiency. |
2003 |
Mol. Genet. Metab. |
pmid:12948743
|
| Pannuzzo G et al. |
A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice. |
2010 |
Mol. Genet. Metab. |
pmid:20418135
|
| Marriage BJ et al. |
Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. |
2004 |
Mol. Genet. Metab. |
pmid:15059613
|
| Haas RH et al. |
The in-depth evaluation of suspected mitochondrial disease. |
2008 |
Mol. Genet. Metab. |
pmid:18243024
|
| Wen B et al. |
Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation. |
2013 |
Mol. Genet. Metab. |
pmid:23628458
|
| Fu R et al. |
Oxidative stress in Niemann-Pick disease, type C. |
2010 Oct-Nov |
Mol. Genet. Metab. |
pmid:20667755
|
| Geromel V et al. |
Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. |
2002 Sep-Oct |
Mol. Genet. Metab. |
pmid:12359126
|
| Hickey MA et al. |
Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease. |
2012 |
Mol. Cell. Neurosci. |
pmid:22044764
|
| Lankin VZ et al. |
Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins. |
2003 |
Mol. Cell. Biochem. |
pmid:12956408
|
| Singh RB et al. |
Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. |
2003 |
Mol. Cell. Biochem. |
pmid:12841346
|
| Perumal SS et al. |
Combined efficacy of tamoxifen and coenzyme Q10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer. |
2005 |
Mol. Cell. Biochem. |
pmid:16013450
|
| Radu F et al. |
The effect of antioxidants on the response of the rabbit urinary bladder to in vitro ischemia/reperfusion. |
2011 |
Mol. Cell. Biochem. |
pmid:21541678
|
| Juan YS et al. |
Coenzyme Q10 protect against ischemia/reperfusion induced biochemical and functional changes in rabbit urinary bladder. |
2008 |
Mol. Cell. Biochem. |
pmid:18165912
|
| Karlsson J et al. |
Coenzyme Q10 and key enzyme activities in papillary muscle related to left ventricle function in mitral valve disease. |
1988 |
Mol. Cell. Biochem. |
pmid:3231216
|
| Littarru GP and Tiano L |
Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. |
2007 |
Mol. Biotechnol. |
pmid:17914161
|
| VerkhovskiÄ MI et al. |
[Kinetics of ubisemiquinone redox changes in primary reactions of bacterial photosynthesis]. |
1981 May-Jun |
Mol. Biol. (Mosk.) |
pmid:6789145
|
| Lenaz G et al. |
Coenzyme Q deficiency in mitochondria: kinetic saturation versus physical saturation. |
1997 |
Mol. Aspects Med. |
pmid:9266503
|
| Ruuge EK et al. |
The redox state of coenzyme Q10 in mitochondrial respiratory chain and oxygen-derived free radical generation in cardiac cells. |
1997 |
Mol. Aspects Med. |
pmid:9266505
|
| Wakabayashi T et al. |
Suppression of the formation of megamitochondria by scavengers for free radicals. |
1997 |
Mol. Aspects Med. |
pmid:9266506
|
| Alleva R et al. |
Oxidation of LDL and their subfractions: kinetic aspects and CoQ10 content. |
1997 |
Mol. Aspects Med. |
pmid:9266511
|
| Oda T |
Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: echocardiographic study. |
1994 |
Mol. Aspects Med. |
pmid:7752826
|
| Morisco C et al. |
Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment. |
1994 |
Mol. Aspects Med. |
pmid:7752827
|
| Langsjoen H et al. |
Usefulness of coenzyme Q10 in clinical cardiology: a long-term study. |
1994 |
Mol. Aspects Med. |
pmid:7752828
|
| Romagnoli A et al. |
Protective role in vivo of coenzyme Q10 during reperfusion of ischemic limbs. |
1994 |
Mol. Aspects Med. |
pmid:7752829
|
| Bargossi AM et al. |
Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. |
1994 |
Mol. Aspects Med. |
pmid:7752830
|
| Iarussi D et al. |
Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. |
1994 |
Mol. Aspects Med. |
pmid:7752832
|
| Lippa S et al. |
Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. |
1994 |
Mol. Aspects Med. |
pmid:7752833
|
| Lodi R et al. |
The use of phosphorus magnetic resonance spectroscopy to study in vivo the effect of coenzyme Q10 treatment in retinitis pigmentosa. |
1994 |
Mol. Aspects Med. |
pmid:7752834
|
